William Hinton

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsEpidemiological methodsSolid tumoursCardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study).

|Oct 24, 2023
Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study.

Bernardo Meza-Torres, Anna Forbes, William Elson

|Sep 01, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study.

Simon de Lusignan, Andrew McGovern, William Hinton

|Aug 25, 2022
Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people.

Hajira Dambha-Miller, William Hinton, Christopher R Wilcox

|Jul 19, 2022
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Michael Feher, William Hinton, Anna Forbes

|May 16, 2022
Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.

Hajira Dambha-Miller, William Hinton, Christopher R Wilcox

Pageof 2

Frequent Collaborators

8 joint publications

Simon de Lusignan

5 joint publications

Mark Joy

5 joint publications

Michael Feher

3 joint publications

Martin Whyte